Sterling’s CEO nominated as top 10 leader in small molecules

10th May 2022

Sterling Pharma Solutions’ CEO, Kevin Cook, has been nominated as one of the top 10 leaders in small molecules. The Power List 2022, compiled annually by the Medicine Maker, celebrates 30 individuals across small molecules, biopharmaceuticals, and advanced therapy.

Kevin has over 30 years’ experience in the pharmaceutical industry, beginning his career as an assistant plant manager before progressing to senior management roles.

When asked by the Medicine Maker, what he would be doing if he wasn’t in the pharma industry, he responded: “I would definitely enjoy working in Formula One! Having to integrate technology, design and innovation, and align these with strategy, managing personalities, marketing, logistics and teamwork among other challenges, to gain a competitive edge.

“While an entirely different field, there are distinct synergies with being the CEO of any business really, except maybe managing the personalities! I think being part of a dynamic, rapidly evolving business such as that would be exciting, but to be honest, just changing tyres in the pit lane would do for me!”

Click here to see the full list.

Related Content


Scientist Snapshot | Kevin Cook, Chief Executive Officer (CEO)

Executive Team



An overview of Sterling Pharma Solutions